Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx

Cellular Microbiology

Volumn 19, Issue 5, 2017, Pages

  Grigorov, Boyan ^a   Reungoat, Emma ^a   Gentil dit Maurin, Alice ^b   Varbanov, Mihayl ^c   Blaising, Julie ^a   Michelet, Maud ^a   Manuel, Rachel ^d   Parent, Romain ^a   Bartosch, Birke ^a   Zoulim, Fabien ^a   Ruggiero, Florence ^d   Pécheur, Eve Isabelle ^a  

^a CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^b CEA GRENOBLE   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

^d UNIVERSITÉ DE LYON   (France)

Author keywords

glycocalyx; heparan sulfate proteoglycan; hepatitis C; hepatocyte; tetraspanin

Indexed keywords

BIOLOGICAL MARKER; CD81 ANTIGEN; CLAUDIN 1; INTERFERON; OCCLUDIN; SCAVENGER RECEPTOR BI; SMALL INTERFERING RNA; SYNDECAN 1; SYNDECAN 4; TRANSFERASE; UNCLASSIFIED DRUG; XYLOSYLTRANSFERASE 2; CD81 PROTEIN, HUMAN; GLYCOSYLTRANSFERASE; SDC1 PROTEIN, HUMAN; UDP XYLOSE-PROTEIN XYLOSYLTRANSFERASE; VIRUS RECEPTOR;

ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; BASOLATERAL MEMBRANE; CELL ASSAY; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOSOME; ENZYME SYNTHESIS; GENE EXPRESSION; GENE SILENCING; GLYCOCALYX; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIVER CELL; NONHUMAN; PRIMARY CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROXIMITY LIGATION ASSAY; VIRION; VIRUS ENTRY; VIRUS INFECTIVITY; CELL MEMBRANE; HEP-G2 CELL LINE; HEPACIVIRUS; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; VIROLOGY; VIRUS REPLICATION;

ANTIGENS, CD81; CELL MEMBRANE; ENDOSOMES; GLYCOCALYX; HEP G2 CELLS; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; PENTOSYLTRANSFERASES; PROTEIN TRANSPORT; RECEPTORS, VIRUS; SYNDECAN-1; VIRUS REPLICATION;

EID: 85007028307     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12711     Document Type: Article

References (49)

1. Bartenschlager, R., Penin, F., Lohmann, V., & André, P. (2011). Assembly of infectious hepatitis C virus particles. Trends in Microbiology, 19, 95–103.
2. Bartosch, B., Dubuisson, J., & Cosset, F.-L. (2003). Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. The Journal of Experimental Medicine, 197, 633–642.
3. Bishop, J. R., Schuksz, M., & Esko, J. D. (2007). Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature, 446, 1030–1037.
4. Blaising, J., Lévy, P.L., Gondeau, C., Phelip, C., Varbanov, M., Teissier, E., … Pécheur, E.I. (2013) Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking. Cellular Microbiology 15: 1866–1882.
5. Bolte, S., & Cordelières, F. P. (2006). A guided tour into subcellular colocalization analysis in light microscopy. Journal of Microscopy, 224, 213–232.
6. Brügger, B., Glass, B., Haberkant, P., Leibrecht, I., Wieland, F. T., & Kräusslich, H.-G. (2006). The HIV lipidome: A raft with an unusual composition. Proceedings of the National Academy of Sciences of the United States of America, 103, 2641–2646.
7. Coller, K. E., Berger, K. L., Heaton, N. S., Cooper, J. D., Yoon, R., & Randall, G. (2009). RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathogens, 5, e1000702.
8. David, G., Bai, X. M., Van der Schueren, B., Cassiman, J. J., & Van den Berghe, H. (1992). Developmental changes in heparan sulfate expression: In situ detection with mAbs. The Journal of Cell Biology, 119, 961–975.
9. Dietrich, C. P., Nader, H. B., & Straus, A. H. (1983). Structural differences of heparan sulfates according to the tissue and species of origin. Biochemical and Biophysical Research Communications, 111, 865–871.
10. Dunn, K. W., Kamocka, M. M., & McDonald, J. H. (2011). A practical guide to evaluating colocalization in biological microscopy. American Journal of Physiology. Cell Physiology, 300, C723–C742.
11. Esko, J. D., & Lindahl, U. (2001). Molecular diversity of heparan sulfate. The Journal of Clinical Investigation, 108, 169–173.
12. Evans, M. J., von Hahn, T., Tscherne, D. M., Syder, A. J., Panis, M., Wölk, B., … Rice, C.M. (2007). Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature, 446, 801–805.
13. Farquhar, M. J., Hu, K., Harris, H. J., Davis, C., Brimacombe, C. L., Fletcher, S. J., McKeating, J. (2012). Hepatitis C virus induces CD81 and claudin-1 endocytosis. Journal of Virology, 86, 4305–4316.
14. Hansen, C. G., & Nichols, B. J. (2009). Molecular mechanisms of clathrin-independent endocytosis. Journal of Cell Science, 122, 1713–1721.
15. Harris, H. J., Davis, C., Mullins, J. G. L., Hu, K., Goodall, M., Farquhar, M. J., … McKeating, J. (2010). Claudin association with CD81 defines hepatitis C virus entry. The Journal of Biological Chemistry, 285, 21092–21102.
16. Hayashida, K., Stahl, P. D., & Park, P. W. (2008). Syndecan-1 ectodomain shedding is regulated by the small GTPase Rab5. The Journal of Biological Chemistry, 283, 35435–35444.
17. Horváth, G., Serru, V., Clay, D., Billard, M., Boucheix, C., & Rubinstein, E. (1998). CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82. The Journal of Biological Chemistry, 273, 30537–30543.
18. Jammart, B., Michelet, M., Pécheur, E.-I., Parent, R., Bartosch, B., Zoulim, F., & Durantel, D. (2013). Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells. Journal of Virology, 87, 5065–5080.
19. Jones, C. T., Catanese, M. T., Law, L. M. J., Khetani, S. R., Syder, A. J., Ploss, A., … Rice, C. M. (2010). Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nature Biotechnology, 28, 167–171.
20. Komurian-Pradel, F., Paranhos-Baccalà, G., Sodoyer, M., Chevallier, P., Mandrand, B., Lotteau, V., & André, P. (2001). Quantitation of HCV RNA using real-time PCR and fluorimetry. Journal of Virological Methods, 95, 111–119.
21. Koutsoudakis, G., Herrmann, E., Kallis, S., Bartenschlager, R., & Pietschmann, T. (2007). The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. Journal of Virology, 81, 588–598.
22. Lamas Longarela, O., Schmidt, T. T., Schöneweis, K., Romeo, R., Wedemeyer, H., Urban, S., & Schulze, A. (2013). Proteoglycans act as cellular hepatitis delta virus attachment receptors. PloS One, 8, e58340.
23. Lambaerts, K., Wilcox-Adelman, S. A., & Zimmermann, P. (2009). The signaling mechanisms of syndecan heparan sulfate proteoglycans. Current Opinion in Cell Biology, 21, 662–669.
24. Laskus, T., Wang, L. F., Radkowski, M., Vargas, H., Nowicki, M., Wilkinson, J., & Rakela, J. (2001). Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain. Journal of Virology, 75, 2059–2066.
25. Lefèvre, M., Felmlee, D. J., Parnot, M., Baumert, T. F., & Schuster, C. (2014). Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein E. PloS One, 9, e95550.
26. Liu, S., Yang, W., Shen, L., Turner, J. R., Coyne, C. B., & Wang, T. (2009). Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. Journal of Virology, 83, 2011–2014.
27. Lyon, M., Deakin, J. A., & Gallagher, J. T. (1994). Liver heparan sulfate structure. A novel molecular design. The Journal of Biological Chemistry, 269, 11208–11215.
28. Manders, E. M. M., Verbeek, F. J., & Aten, J. A. (1993). Measurement of co-localization of objects in dual-colour confocal images. Journal of Microscopy, 169, 375–382.
29. Morikawa, K., Zhao, Z., Date, T., Miyamoto, M., Murayama, A., Akazawa, D., … Wakita, T. (2007). The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles. Journal of Medical Virology, 79, 714–723.
30. Mosier, P. D., Krishnasamy, C., Kellogg, G. E., & Desai, U. R. (2012). On the specificity of heparin/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different. PloS One, 7, e48632.
31. Pichard, L., Raulet, E., Fabre, G., Ferrini, J. B., Ourlin, J.-C., & Maurel, P. (2006). Human hepatocyte culture. Methods in Molecular Biology Clifton NJ, 320, 283–293.
32. Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., … Abrignani, S. (1998). Binding of hepatitis C virus to CD81. Science, 282, 938–941.
33. Ploss, A., Evans, M. J., Gaysinskaya, V. A., Panis, M., You, H., de Jong, Y. P., & Rice, C. M. (2009). Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature, 457, 882–886.
34. Pönighaus, C., Ambrosius, M., Casanova, J. C., Prante, C., Kuhn, J., Esko, J. D., … Götting, C. (2007). Human xylosyltransferase II is involved in the biosynthesis of the uniform tetrasaccharide linkage region in chondroitin sulfate and heparan sulfate proteoglycans. The Journal of Biological Chemistry, 282, 5201–5206.
35. Ramírez, S., Pérez-del-Pulgar, S., Carrión, J. A., Coto-Llerena, M., Mensa, L., Dragun, J., … Forns, X. (2010). Hepatitis C virus superinfection of liver grafts: A detailed analysis of early exclusion of non-dominant virus strains. The Journal of General Virology, 91, 1183–1188.
36. Reitsma, S., Slaaf, D. W., Vink, H., van Zandvoort, M. A. M. J., & oude Egbrink, M. G. A. (2007). The endothelial glycocalyx: Composition, functions, and visualization. Pflügers Archiv - European Journal of Physiology, 454, 345–359.
37. Reynolds, G. M., Harris, H. J., Jennings, A., Hu, K., Grove, J., Lalor, P. F., … McKeating, J. (2008). Hepatitis C virus receptor expression in normal and diseased liver tissue. Hepatology Baltimore Md, 47, 418–427.
38. Sainz, B., Barretto, N., Martin, D. N., Hiraga, N., Imamura, M., Hussain, S., … Uprichard, S. (2012). Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nature Medicine, 18, 281–285.
39. Sasisekharan, R., & Venkataraman, G. (2000). Heparin and heparan sulfate: biosynthesis, structure and function. Current Opinion in Chemical Biology, 4, 626–631.
40. Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M., Acali, S., Filocamo, G., … Vitelli, A. (2002). The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. The EMBO Journal, 21, 5017–5025.
41. Schulze, A., Gripon, P., & Urban, S. (2007). Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology Baltimore Md, 46, 1759–1768.
42. Shi, Q., Jiang, J., & Luo, G. (2013). Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes. Journal of Virology, 87, 6866–6875.
43. Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K.-J., Jarvius, J., … Landegren, U. (2006). Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nature Methods, 3, 995–1000.
44. Stanford, K. I., Bishop, J. R., Foley, E. M., Gonzales, J. C., Niesman, I. R., Witztum, J. L., & Esko, J. D. (2009). Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice. The Journal of Clinical Investigation, 119, 3236–3245.
45. Sutton, A., Friand, V., Brulé-Donneger, S., Chaigneau, T., Ziol, M., Sainte-Catherine, O., Charnaux, N. (2007). Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion. Molecular Cancer Research MCR, 5, 21–33.
46. Toida, T., Yoshida, H., Toyoda, H., Koshiishi, I., Imanari, T., Hileman, R. E., … Linhardt, R.J. (1997). Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. The Biochemical Journal, 322(Pt 2), 499–506.
47. Tscherne, D.M., Evans, M.J., Hahn, T. von, Jones, C.T., Stamataki, Z., McKeating, J.A., … Rice, C.M. (2007) Superinfection exclusion in cells infected with hepatitis C virus. Journal of Virology 81: 3693–3703.
48. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., … Liang, T.J. (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature Medicine, 11, 791–796.
49. Woods, A., & Couchman, J. R. (2001). Syndecan-4 and focal adhesion function. Current Opinion in Cell Biology, 13, 578–583.